Medicare Enrolled
Dr. David Konanc, M.D.
Neurology · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Konanc from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Konanc?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Konanc
Dr. David Konanc is a neurology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Konanc performed 59,470 Medicare services across 755 unique beneficiaries.
Between the years covered by Open Payments, Dr. Konanc received a total of $12,631 from 83 pharmaceutical and/or device companies across 704 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Konanc is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NC
$12,631 industry payments
Medicare Practice Summary
Medicare Utilization ↗59,470
Medicare services
Top 1% in NC for neurology
755
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,974 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
42,871 | $5 | $13 |
| Injection, natalizumab, 1 mg | 6,600 | $19 | $35 |
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
5,200 | $4 | $11 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,480 | $38 | $90 |
| MRI contrast dye injection (gadobutrol) | 1,330 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $61 | $150 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 141 | $56 | $400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $110 | $380 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $89 | $220 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
65 | $139 | $530 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
53 | $102 | $475 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $15 | $166 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
43 | $103 | $549 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
42 | $46 | $228 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
34 | $127 | $622 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
34 | $86 | $510 |
| New patient office visit, complex (60-74 min) | 34 | $154 | $430 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 33 | $69 | $362 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
31 | $111 | $560 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
28 | $97 | $1,980 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
28 | $10 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $70 | $266 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $121 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
98.9% medium
0.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,631
Total received (2018-2024)
Avg $1,804/year across 7 years
Top 18% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
704
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,906 (94.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$524 (4.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$201 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,949
2023
$2,331
2022
$2,238
2021
$260
2020
$316
2019
$2,211
2018
$2,326
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$333
ABBVIE INC.
$263
MDD US Operations, LLC
$248
Novartis Pharmaceuticals Corporation
$201
Eisai Inc.
$163
Lilly USA, LLC
$162
Amgen Inc.
$153
UCB, Inc.
$153
Lundbeck LLC
$119
Neurocrine Biosciences, Inc.
$107
PFIZER INC.
$94
Teva Pharmaceuticals USA, Inc.
$89
ARGENX US, INC.
$82
TG Therapeutics, Inc.
$78
Neurelis, Inc.
$64
Kyowa Kirin, Inc.
$57
HARMONY BIOSCIENCES LLC
$55
Takeda Pharmaceuticals U.S.A., Inc.
$54
Biogen, Inc.
$52
Genentech USA, Inc.
$49
Ipsen Biopharmaceuticals, Inc
$42
Grifols USA, LLC
$39
SK Life Science, Inc.
$39
Acorda Therapeutics, Inc
$35
ACADIA Pharmaceuticals Inc
$30
CATALYST PHARMACEUTICALS, INC.
$27
EMD Serono, Inc.
$27
Axsome Therapeutics, Inc.
$26
NEUROPACE, INC.
$25
Siemens Medical Solutions USA, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$18
AstraZeneca Pharmaceuticals LP
$17
Celgene Corporation
$17
Aucta Pharmaceuticals, Inc.
$14
Top 3 companies account for 28.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$946
GENZYME CORPORATION
$946
Alexion Pharmaceuticals, Inc.
$806
ABBVIE INC.
$721
Biogen, Inc.
$518
Genentech USA, Inc.
$512
MDD US Operations, LLC
$477
Neurocrine Biosciences, Inc.
$426
UCB, Inc.
$422
Teva Pharmaceuticals USA, Inc.
$357
Lilly USA, LLC
$352
Amgen Inc.
$300
ARGENX US, INC.
$287
Lundbeck LLC
$279
EMD Serono, Inc.
$278
Acorda Therapeutics, Inc
$268
Eisai Inc.
$250
Avanir Pharmaceuticals, Inc.
$226
Janssen Pharmaceuticals, Inc
$219
Sunovion Pharmaceuticals Inc.
$208
Neurelis, Inc.
$205
ACADIA Pharmaceuticals Inc
$193
Avion Pharmaceuticals
$192
Allergan Inc.
$180
PFIZER INC.
$159
Merz North America, Inc.
$156
SK Life Science, Inc.
$148
Grifols USA, LLC
$138
CSL Behring
$136
Mitsubishi Tanabe Pharma America, Inc.
$117
Amneal Pharmaceuticals LLC
$113
IMPEL PHARMACEUTICALS INC.
$92
Adamas Pharmaceuticals, Inc.
$90
Ipsen Biopharmaceuticals, Inc
$88
Promius Pharma LLC
$84
Kyowa Kirin, Inc.
$81
Assertio Therapeutics, Inc.
$79
TG Therapeutics, Inc.
$78
Allergan, Inc.
$75
ARBOR PHARMACEUTICALS, INC.
$70
Bausch Health US, LLC
$65
Celgene Corporation
$64
Jazz Pharmaceuticals Inc.
$63
GRT US Holding, Inc.
$57
HARMONY BIOSCIENCES LLC
$55
Takeda Pharmaceuticals U.S.A., Inc.
$54
Collegium Pharmaceutical, Inc.
$52
Arbor Pharmaceuticals, Inc.
$48
AQUESTIVE THERAPEUTICS, INC.
$46
Mallinckrodt LLC
$44
ASSERTIO THERAPEUTICS, Inc.
$44
Mallinckrodt Enterprises LLC
$42
Upsher-Smith Laboratories LLC
$39
Catalyst Pharmaceuticals, Inc.
$38
JAZZ PHARMACEUTICALS INC.
$36
Microtransponder, Inc.
$35
AstraZeneca Pharmaceuticals LP
$35
IDORSIA PHARMACEUTICALS US INC
$32
Supernus Pharmaceuticals, Inc.
$30
AbbVie Inc.
$29
Merz Pharmaceuticals, LLC
$28
CATALYST PHARMACEUTICALS, INC.
$27
LivaNova USA, Inc.
$26
Axsome Therapeutics, Inc.
$26
Strongbridge US INC.
$26
NEUROPACE, INC.
$25
GE HEALTHCARE
$25
GE HealthCare
$25
Banner Life Sciences, LLC
$22
Octapharma USA, Inc.
$19
Sumitomo Pharma America, Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
Siemens Medical Solutions USA, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Cala Health, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Mallinckrodt Hospital Products Inc.
$16
ANI Pharmaceuticals, Inc.
$16
Aucta Pharmaceuticals, Inc.
$14
Biohaven Pharmaceutical Holding Company Ltd.
$14
Currax Pharmaceuticals LLC
$13
Kowa Pharmaceuticals America, Inc.
$13
Boston Scientific Corporation
$11
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Biograph Vision 600 (8 Ring/64 CT) · Briviact · CALA TRIO · COPAXONE · Cambia · DUOPA · DYSPORT · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · Eprontia · FIRDAPSE · FYCOMPA · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · HyperRAB · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LYVISPAH · Leqembi · MAYZENT · MIGRANAL · MS DISEASE STATE · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · ONZETRA XSAIL · ONZETRA Xsail · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · Prolia · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qutenza · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Seglentis · Soliris · Sunosi · TALTZ · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · XEOMIN · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Konanc is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with low-engagement industry engagement in the top 18% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Konanc experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Konanc performed 42,871 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Konanc receive payments from pharmaceutical companies?
Yes. Dr. Konanc received a total of $12,631 from 83 companies across 704 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Konanc's costs compare to other neurologists in Raleigh?
Dr. Konanc's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Konanc) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Raleigh
Browse neurologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology